About 70% of breast cancer tumors are Luminal A (ER+/PR±/HER2-) with triple negative, commonly referred as TNBC (ER-/PR-/HER2-), and Luminal B (ER+/PR±/HER2±) accounting for 10% each. The gene discussed is ERBB2; the disease is breast carcinoma.